Skip to content

Effect of oral L-carnitine on echocardiography of dialysis patients

Evaluation of the effect of oral l-carnitine on echocardiography criteria in patients with pulmonary artery hypertension due to dialysis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230425057989N1
Enrollment
40
Registered
2023-05-07
Start date
2023-05-09
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary hypertension. Other secondary pulmonary hypertension

Interventions

Intervention 1: Intervention group: First, echocardiography, 6-minute walk test (6MWT) and NYHA criteria are examined for patients. The results of 6MWT distance, pulse count and distance covered durin

Sponsors

Shahre-kord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to No maximum

Inclusion criteria

Inclusion criteria: More than 13 years of age History of at least six months of hemodialysis Having a case in the dialysis department Performing dialysis 2 or 3 times a week for 3-4 hours each time Not having physical and mental disabilities The patient's dry weight remains constant

Exclusion criteria

Exclusion criteria: Suffering from chronic physical disorders such as heart, respiratory, and liver diseases Kidney transplant history Unwillingness to continue cooperation Death Travel Occurrence of unwanted drug side effects Not taking medicine for more than a week

Design outcomes

Primary

MeasureTime frame
Pulmonary artery pressure. Timepoint: Before and after 3 months from the start of the intervention. Method of measurement: Echocardiography.;Arterial oxygen saturation. Timepoint: Before and after 3 months from the start of the intervention. Method of measurement: Pulse oximetry.

Secondary

MeasureTime frame
Number of times of hemodialysis per week. Timepoint: Before and after 3 months from the start of the intervention. Method of measurement: Number of times of hemodialysis per week.;Right ventricular function. Timepoint: Before and after 3 months from the start of the intervention. Method of measurement: Echocardiography.;Shortness of breath. Timepoint: Before and after 3 months from the start of the intervention. Method of measurement: NYHA (New York Heart Association Functional Classification).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfiyeh Mirzaali

Shahre-kord University of Medical Sciences

afiyeh.mirzaali@gmail.com+98 38 3222 0016

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 5, 2026